OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report)’s stock price gapped down before the market opened on Wednesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $32.00. The stock had previously closed at $22.89, but opened at $22.28. Stifel Nicolaus currently has a buy rating on the stock. OrthoPediatrics shares last traded at $23.69, with a volume of 12,976 shares trading hands.
Other equities research analysts also recently issued research reports about the stock. Truist Financial reduced their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday.
Read Our Latest Analysis on KIDS
Institutional Inflows and Outflows
OrthoPediatrics Stock Performance
The business has a fifty day simple moving average of $24.45 and a two-hundred day simple moving average of $25.93. The company has a market cap of $608.06 million, a P/E ratio of -20.41 and a beta of 1.14. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.
OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million for the quarter, compared to the consensus estimate of $51.16 million. During the same quarter last year, the firm posted ($0.23) earnings per share. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.
About OrthoPediatrics
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
See Also
- Five stocks we like better than OrthoPediatrics
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- What is a SEC Filing?
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- How to Invest in Biotech Stocks
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.